Loading...
Loading...
Analysts at Leerink Swann upgraded MedAssets
MDAS from Market Perform to Outperform.
The target price for MedAssets is set to $26.
MedAssets shares have fallen 6.51% over the past 52 weeks, while the S&P 500 index has gained 19.79% in the same period.
MedAssets' shares rose 0.28% to close at $21.25 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in